Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Medicago
Medicago
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Design & Build
Medicago contributes CA$500,000 to help establish Class 3 containment laboratory at Université Laval
Remaining two-thirds of the funds will be provided by the City of Quebec and the research centre's foundation
Research & Development
Medicago to develop Ebola monoclonal antibodies for the Canadian government
Plant-based antibodies to be developed in mini-factories to fight the Sudan strain of the Ebola virus
Manufacturing
Medicago to build C$245m vaccine production facility in Quebec City, Canada
Will create 200 new highly skilled jobs by 2019
Finance
Mitsubishi Tanabe Pharma to acquire Medicago for $357m
Medicago has been collaborating with MTPC since 2012 to develop and commercialise rotavirus VLP-based vaccines
Manufacturing
Medicago produces rotavirus VLP vaccine candidate
It comprises all four structural antigens of rotavirus using its plant-based manufacturing platform
Research & Development
Medicago and Mitsubishi to develop next generation technology for plant production
Companies to evaluate closed hydroponic Plant Factory System
Research & Development
Canadian government awards US$493,000 to Medicago
To support development of new potency assays and process analytical technologies
Subscribe now